FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Robinson James George 2. Issuer Name and Ticker or Trading Symbol NYMOX PHARMACEUTICAL CORP [ nymx ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
10 EAST LEE STREET, SUITE 2705
3. Date of Earliest Transaction (MM/DD/YYYY)
4/21/2021
(Street)
BALTIMORE, MD 21202
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  4/21/2021    P    2000  A $2.0899  3512550  D   
Common Stock  4/21/2021    P    6000  A $2.08  3518550  D   
Common Stock  4/21/2021    P    4100  A $2.0799  3522650  D   
Common Stock  4/21/2021    P    900  A $2.0782  3523550  D   
Common Stock  4/22/2021    P    7000  A $2.0699  3530550  D   
Common Stock  4/22/2021    P    1900  A $2.1299  3532450  D   
Common Stock  4/22/2021    P    3100  A $2.105  3535550  D   
Common Stock  4/22/2021    P    5000  A $2.05  3540550  D   
Common Stock  4/22/2021    P    4949  A $2.0899  3545499  D   
Common Stock  4/22/2021    P    51  A $2.08  3545550  D   
Common Stock  4/22/2021    P    800  A $2.1  3546350  D   
Common Stock  4/22/2021    P    2900  A $2.0899  3549250  D   
Common Stock  4/22/2021    P    1100  A $2.0882  3550350  D   
Common Stock  4/22/2021    P    200  A $2.085  3550550  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Robinson James George
10 EAST LEE STREET
SUITE 2705
BALTIMORE, MD 21202
X



Signatures
James G Robinson 4/27/2021
**Signature of Reporting Person Date
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Nymox Pharmaceutical Charts.
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Nymox Pharmaceutical Charts.